Ephrin A1 - A Recombinant Protein Approach to Reduce Hospital Readmission and Improve Outcomes Following Coronary Artery Bypass Grafting
NCBiotech Grants & Loans
See the full listing of all NCBiotech grants and loans awarded since July 2012.
Organization
East Carolina University
Award Date
Award Amount
110,000
Program Name
Translational Research Grant
Program Category
Research and Equipment Support
Principal Investigator
Jitka Virag
Fiscal Year
2022
Region
Eastern
Project Description:
Researchers at ECU are developing a recombinant protein therapeutic to stabilize and protect heart tissue following coronary artery bypass surgery, which is expected to reduce cardiac-related hospital readmissions and improve patient outcomes.